1. Short-Term Hypoxia Dampens Inflammation in vivo via Enhanced Adenosine Release and Adenosine 2B Receptor Stimulation
- Author
-
Dorien Kiers, Ben Wielockx, Esther Peters, Lucas T. van Eijk, Jelle Gerretsen, Aaron John, Emmy Janssen, Rianne Groeneveld, Mara Peters, Lars Damen, Ana M. Meneses, Anja Krüger, Jeroen D. Langereis, Aldert L. Zomer, Michael R. Blackburn, Leo A. Joosten, Mihai G. Netea, Niels P. Riksen, Johannes G. van der Hoeven, Gert-Jan Scheffer, Holger K. Eltzschig, Peter Pickkers, and Matthijs Kox
- Subjects
Medicine ,Medicine (General) ,R5-920 - Abstract
Hypoxia and inflammation are closely intertwined phenomena. Critically ill patients often suffer from systemic inflammatory conditions and concurrently experience short-lived hypoxia. We evaluated the effects of short-term hypoxia on systemic inflammation, and show that it potently attenuates pro-inflammatory cytokine responses during murine endotoxemia. These effects are independent of hypoxia-inducible factors (HIFs), but involve augmented adenosine levels, in turn resulting in an adenosine 2B receptor-mediated post-transcriptional increase of interleukin (IL)-10 production. We translated our findings to humans using the experimental endotoxemia model, where short-term hypoxia resulted in enhanced plasma concentrations of adenosine, augmentation of endotoxin-induced circulating IL-10 levels, and concurrent attenuation of the pro-inflammatory cytokine response. Again, HIFs were shown not to be involved. Taken together, we demonstrate that short-term hypoxia dampens the systemic pro-inflammatory cytokine response through enhanced purinergic signaling in mice and men. These effects may contribute to outcome and provide leads for immunomodulatory treatment strategies for critically ill patients. Keywords: Adenosine, Adenosine 2B receptor, Cytokines, Hypoxia, Endotoxin
- Published
- 2018
- Full Text
- View/download PDF